<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genet Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet. Med</journal-id>
<journal-title-group>
<journal-title>Genetics in Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1098-3600</issn>
<issn pub-type="epub">1530-0366</issn>
<publisher>
<publisher-name>Nature Publishing Group US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31239556</article-id>
<article-id pub-id-type="pmc">6892744</article-id>
<article-id pub-id-type="publisher-id">585</article-id>
<article-id pub-id-type="doi">10.1038/s41436-019-0585-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>CTCF</italic> variants in 39
individuals with a variable neurodevelopmental disorder broaden the mutational and
clinical spectrum</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Konrad</surname>
<given-names>Enrico D. H.</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nardini</surname>
<given-names>Niels</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caliebe</surname>
<given-names>Almuth</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagel</surname>
<given-names>Inga</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0209-1156</contrib-id>
<name>
<surname>Young</surname>
<given-names>Dana</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horvath</surname>
<given-names>Gabriella</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santoro</surname>
<given-names>Stephanie L.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shuss</surname>
<given-names>Christine</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ziegler</surname>
<given-names>Alban</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonneau</surname>
<given-names>Dominique</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kempers</surname>
<given-names>Marlies</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pfundt</surname>
<given-names>Rolph</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Legius</surname>
<given-names>Eric</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bouman</surname>
<given-names>Arjan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stuurman</surname>
<given-names>Kyra E.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4594-6364</contrib-id>
<name>
<surname>Õunap</surname>
<given-names>Katrin</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff10">10</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5435-0781</contrib-id>
<name>
<surname>Pajusalu</surname>
<given-names>Sander</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff10">10</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8162-5031</contrib-id>
<name>
<surname>Wojcik</surname>
<given-names>Monica H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff12">12</xref>
<xref ref-type="aff" rid="Aff14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasileiou</surname>
<given-names>Georgia</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Le Guyader</surname>
<given-names>Gwenaël</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schnelle</surname>
<given-names>Hege M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8048-6682</contrib-id>
<name>
<surname>Berland</surname>
<given-names>Siren</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9503-6297</contrib-id>
<name>
<surname>Zonneveld-Huijssoon</surname>
<given-names>Evelien</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0251-5564</contrib-id>
<name>
<surname>Kersten</surname>
<given-names>Simone</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3647-8148</contrib-id>
<name>
<surname>Gupta</surname>
<given-names>Aditi</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff18">18</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0658-1275</contrib-id>
<name>
<surname>Blackburn</surname>
<given-names>Patrick R.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1710-8854</contrib-id>
<name>
<surname>Ellingson</surname>
<given-names>Marissa S.</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferber</surname>
<given-names>Matthew J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8052-2586</contrib-id>
<name>
<surname>Dhamija</surname>
<given-names>Radhika</given-names>
</name>
<degrees>MBBS</degrees>
<xref ref-type="aff" rid="Aff20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klee</surname>
<given-names>Eric W.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McEntagart</surname>
<given-names>Meriel</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lichtenbelt</surname>
<given-names>Klaske D.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kenney</surname>
<given-names>Amy</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vergano</surname>
<given-names>Samantha A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abou Jamra</surname>
<given-names>Rami</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Platzer</surname>
<given-names>Konrad</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff24">24</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9943-5236</contrib-id>
<name>
<surname>Ella Pierpont</surname>
<given-names>Mary</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff25">25</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khattar</surname>
<given-names>Divya</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff26">26</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0770-5516</contrib-id>
<name>
<surname>Hopkin</surname>
<given-names>Robert J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff26">26</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Richard J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff27">27</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jongmans</surname>
<given-names>Marjolijn C. J.</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Vivian Y.</given-names>
</name>
<degrees>MD MS</degrees>
<xref ref-type="aff" rid="Aff28">28</xref>
<xref ref-type="aff" rid="Aff29">29</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez-Agosto</surname>
<given-names>Julian A.</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff30">30</xref>
<xref ref-type="aff" rid="Aff31">31</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuismin</surname>
<given-names>Outi</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff32">32</xref>
<xref ref-type="aff" rid="Aff33">33</xref>
<xref ref-type="aff" rid="Aff34">34</xref>
<xref ref-type="aff" rid="Aff35">35</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kurki</surname>
<given-names>Mitja I.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff32">32</xref>
<xref ref-type="aff" rid="Aff36">36</xref>
<xref ref-type="aff" rid="Aff37">37</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pietiläinen</surname>
<given-names>Olli</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff37">37</xref>
<xref ref-type="aff" rid="Aff38">38</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palotie</surname>
<given-names>Aarno</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff32">32</xref>
<xref ref-type="aff" rid="Aff36">36</xref>
<xref ref-type="aff" rid="Aff37">37</xref>
<xref ref-type="aff" rid="Aff39">39</xref>
<xref ref-type="aff" rid="Aff40">40</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maarup</surname>
<given-names>Timothy J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff41">41</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Diana S.</given-names>
</name>
<degrees>BM MD</degrees>
<xref ref-type="aff" rid="Aff42">42</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Venborg Pedersen</surname>
<given-names>Katja</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff43">43</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laulund</surname>
<given-names>Lone W.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff44">44</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lynch</surname>
<given-names>Sally A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff45">45</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4312-413X</contrib-id>
<name>
<surname>Blyth</surname>
<given-names>Moira</given-names>
</name>
<degrees>MBChB DM</degrees>
<xref ref-type="aff" rid="Aff46">46</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prescott</surname>
<given-names>Katrina</given-names>
</name>
<degrees>MBBS PhD</degrees>
<xref ref-type="aff" rid="Aff46">46</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canham</surname>
<given-names>Natalie</given-names>
</name>
<degrees>MB, ChB</degrees>
<xref ref-type="aff" rid="Aff47">47</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ibitoye</surname>
<given-names>Rita</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff47">47</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brilstra</surname>
<given-names>Eva H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shinawi</surname>
<given-names>Marwan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="Aff48">48</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fassi</surname>
<given-names>Emily</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="Aff48">48</xref>
</contrib>
<contrib contrib-type="author">
<collab>DDD Study</collab>
<xref ref-type="aff" rid="Aff49">49</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5644-045X</contrib-id>
<name>
<surname>Sticht</surname>
<given-names>Heinrich</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff50">50</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9166-6593</contrib-id>
<name>
<surname>Gregor</surname>
<given-names>Anne</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Van Esch</surname>
<given-names>Hilde</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="Aff51">51</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8002-2020</contrib-id>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
<degrees> MD PhD</degrees>
<address>
<email>christiane.zweier@uk-erlangen.de</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Institute of Human Genetics, </institution><institution>Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), </institution></institution-wrap>Erlangen, Germany </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2153 9986</institution-id><institution-id institution-id-type="GRID">grid.9764.c</institution-id><institution>Institute of Human Genetics, </institution><institution>Universitätsklinikum Schleswig Holstein Campus Kiel and
Christian-Albrechts-Universität, </institution></institution-wrap>Kiel, Germany </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 2097</institution-id><institution-id institution-id-type="GRID">grid.412468.d</institution-id><institution>Institute of Experimental and Clinical Pharmacology, </institution><institution>University Hospital Schleswig-Holstein, Campus Kiel, </institution></institution-wrap>Kiel, Germany </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0684 7796</institution-id><institution-id institution-id-type="GRID">grid.412541.7</institution-id><institution>Adult Metabolic Diseases Clinic, </institution><institution>Vancouver General Hospital, </institution></institution-wrap>Vancouver, BC Canada </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0392 3476</institution-id><institution-id institution-id-type="GRID">grid.240344.5</institution-id><institution>Division of Molecular and Human Genetics, </institution><institution>Nationwide Children’s Hospital, </institution></institution-wrap>Columbus, OH USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0472 0283</institution-id><institution-id institution-id-type="GRID">grid.411147.6</institution-id><institution>Département de Biochimie et Génétique, </institution><institution>CHU Angers et Mitolab INSERM 1083—CNRS 6015, </institution></institution-wrap>Angers, France </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.461760.2</institution-id><institution>Department of Human Genetics, </institution><institution>Radboud University Medical Center and Radboud Institute for Molecular Life
Sciences, </institution></institution-wrap>Nijmegen, The Netherlands </aff>
<aff id="Aff8"><label>8</label>Department of Human Genetics, KU Leuven and Center for Human Genetics, University Hospital Leuven, KU
Leuven, Leuven, Belgium </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">000000040459992X</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution>Department of Clinical Genetics, </institution><institution>Erasmus MC, University Medical Center Rotterdam, </institution></institution-wrap>Rotterdam, The Netherlands </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0585 7044</institution-id><institution-id institution-id-type="GRID">grid.412269.a</institution-id><institution>Department of Clinical Genetics, </institution><institution>United Laboratories, Tartu University Hospital, </institution></institution-wrap>Tartu, Estonia </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0943 7661</institution-id><institution-id institution-id-type="GRID">grid.10939.32</institution-id><institution>Department of Clinical Genetics, </institution><institution>Institute of Clinical Medicine, University of Tartu, </institution></institution-wrap>Tartu, Estonia </aff>
<aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>The Broad Institute of MIT and Harvard, </institution></institution-wrap>Cambridge, MA USA </aff>
<aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution>Department of Genetics, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
<aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0378 8438</institution-id><institution-id institution-id-type="GRID">grid.2515.3</institution-id><institution>Divisions of Genetics and Genomics and Newborn Medicine, Department of
Pediatrics, </institution><institution>Boston Children’s Hospital, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9336 4276</institution-id><institution-id institution-id-type="GRID">grid.411162.1</institution-id><institution>Service de Génétique Clinique, CHU de Poitiers, </institution></institution-wrap>Poitiers, France </aff>
<aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9753 1393</institution-id><institution-id institution-id-type="GRID">grid.412008.f</institution-id><institution>Department of Medical Genetics, </institution><institution>Haukeland University Hospital, </institution></institution-wrap>Bergen, Norway </aff>
<aff id="Aff17"><label>17</label>Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands </aff>
<aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution>Center for Individualized Medicine, </institution><institution>Mayo Clinic, </institution></institution-wrap>Rochester, MN USA </aff>
<aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution>Department of Laboratory Medicine and Pathology, </institution><institution>Mayo Clinic, </institution></institution-wrap>Rochester, MN USA </aff>
<aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8875 6339</institution-id><institution-id institution-id-type="GRID">grid.417468.8</institution-id><institution>Department of Clinical Genomics, </institution><institution>Mayo Clinic, </institution></institution-wrap>Scottsdale, AZ USA </aff>
<aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution>South West Thames Regional Genetics Centre, </institution><institution>St. George’s Healthcare NHS Trust, St. George’s, University of
London, </institution></institution-wrap>London, UK </aff>
<aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ISNI">0000000090126352</institution-id><institution-id institution-id-type="GRID">grid.7692.a</institution-id><institution>Department of Genetics, </institution><institution>University Medical Center Utrecht, </institution></institution-wrap>Utrecht, The Netherlands </aff>
<aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0426 1259</institution-id><institution-id institution-id-type="GRID">grid.414165.3</institution-id><institution>Division of Medical Genetics and Metabolism, </institution><institution>Children’s Hospital of The King’s Daughters, </institution></institution-wrap>Norfolk, VA USA </aff>
<aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2230 9752</institution-id><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution>Institute of Human Genetics, </institution><institution>University of Leipzig Medical Center, </institution></institution-wrap>Leipzig, Germany </aff>
<aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368657</institution-id><institution-id institution-id-type="GRID">grid.17635.36</institution-id><institution>Department of Pediatrics, Division of Genetics and
Metabolism, </institution><institution>University of Minnesota, </institution></institution-wrap>Minneapolis, MN USA </aff>
<aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9025 8099</institution-id><institution-id institution-id-type="GRID">grid.239573.9</institution-id><institution>Division of Human Genetics, </institution><institution>Cincinnati Children’s Hospital Medical Center, </institution></institution-wrap>Cincinnati, OH USA </aff>
<aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0444 2244</institution-id><institution-id institution-id-type="GRID">grid.420004.2</institution-id><institution>The Newcastle upon Tyne Hospitals NHS Foundation Trust, </institution></institution-wrap>Newcastle upon Tyne, UK </aff>
<aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Division of Pediatric Hematology-Oncology, Department of
Pediatrics, </institution><institution>David Geffen School of Medicine, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Jonsson Comprehensive Cancer Center, </institution><institution>University of California, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Division of Medical Genetics, Department of Pediatrics, </institution><institution>David Geffen School of Medicine, University of California, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Department of Human Genetics, </institution><institution>David Geffen School of Medicine, University of California, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution>Institute for Molecular Medicine Finland, </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff>
<aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0941 4873</institution-id><institution-id institution-id-type="GRID">grid.10858.34</institution-id><institution>PEDEGO Research Unit, </institution><institution>University of Oulu, </institution></institution-wrap>Oulu, Finland </aff>
<aff id="Aff34"><label>34</label>Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland </aff>
<aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4685 4917</institution-id><institution-id institution-id-type="GRID">grid.412326.0</institution-id><institution>Department of Clinical Genetics, </institution><institution>Oulu University Hospital, </institution></institution-wrap>Oulu, Finland </aff>
<aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Psychiatric &amp; Neurodevelopmental Genetics Unit, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>The Stanley Center for Psychiatric Research, </institution><institution>The Broad Institute of MIT and Harvard, </institution></institution-wrap>Cambridge, MA USA </aff>
<aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution>Department of Stem Cell and Regenerative Biology, </institution><institution>University of Harvard, </institution></institution-wrap>Cambridge, MA USA </aff>
<aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Analytic and Translational Genetics Unit, Department of
Medicine, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Department of Neurology, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0445 1191</institution-id><institution-id institution-id-type="GRID">grid.414895.5</institution-id><institution>Department of Genetics, </institution><institution>Kaiser Permanente, </institution></institution-wrap>Los Angeles, CA USA </aff>
<aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0641 6082</institution-id><institution-id institution-id-type="GRID">grid.413991.7</institution-id><institution>Sheffield Children’s Hospital, </institution></institution-wrap>Sheffield, UK </aff>
<aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0512 5013</institution-id><institution-id institution-id-type="GRID">grid.7143.1</institution-id><institution>Department of Clinical Genetics, </institution><institution>Odense University Hospital, </institution></institution-wrap>Odense, Denmark </aff>
<aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0512 5013</institution-id><institution-id institution-id-type="GRID">grid.7143.1</institution-id><institution>Department of Pediatrics, </institution><institution>Odense University Hospital, </institution></institution-wrap>Odense, Denmark </aff>
<aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0768 2743</institution-id><institution-id institution-id-type="GRID">grid.7886.1</institution-id><institution>University College Dublin and Temple Street Children’s Hospital, </institution></institution-wrap>Dublin, Ireland </aff>
<aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0426 1312</institution-id><institution-id institution-id-type="GRID">grid.413818.7</institution-id><institution>Yorkshire Regional Genetics Service, </institution><institution>Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, </institution></institution-wrap>Leeds, UK </aff>
<aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0398 9627</institution-id><institution-id institution-id-type="GRID">grid.416568.8</institution-id><institution>North West Thames Regional Genetics Service, </institution><institution>Northwick Park Hospital, </institution></institution-wrap>Harrow, UK </aff>
<aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution>Division of Genetics and Genomic Medicine, Department of
Pediatrics, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff>
<aff id="Aff49"><label>49</label>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK </aff>
<aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Institute of Biochemistry, </institution><institution>Emil-Fischer Center, Friedrich-Alexander-Universität
Erlangen-Nürnberg, </institution></institution-wrap>Erlangen, Germany </aff>
<aff id="Aff51"><label>51</label>Center for Human Genetics, University Hospital Leuven, KU Leuven, Leuven, Belgium </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>21</volume>
<issue>12</issue>
<fpage>2723</fpage>
<lpage>2733</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
License, which permits any non-commercial use, sharing, adaptation, distribution
and reproduction in any medium or format, as long as you give appropriate credit
to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. If you remix, transform, or build
upon this article or a part thereof, you must distribute your contributions
under the same license as the original. The images or other third party material
in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to
obtain permission directly from the copyright holder. To view a copy of this
license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Purpose</title>
<p id="Par1">Pathogenic variants in the chromatin organizer <italic>CTCF</italic> were previously reported in seven individuals
with a neurodevelopmental disorder (NDD).</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Through international collaboration we collected data from 39
subjects with variants in <italic>CTCF</italic>. We performed
transcriptome analysis on RNA from blood samples and utilized <italic>Drosophila melanogaster</italic> to investigate the impact
of <italic>Ctcf</italic> dosage alteration on nervous system
development and function.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">The individuals in our cohort carried 2 deletions, 8 likely
gene-disruptive, 2 splice-site, and 20 different missense variants, most of them
de novo. Two cases were familial. The associated phenotype was of variable
severity extending from mild developmental delay or normal IQ to severe
intellectual disability. Feeding difficulties and behavioral abnormalities were
common, and variable other findings including growth restriction and cardiac
defects were observed. RNA-sequencing in five individuals identified 3828
deregulated genes enriched for known NDD genes and biological processes such as
transcriptional regulation. <italic>Ctcf</italic> dosage
alteration in <italic>Drosophila</italic> resulted in impaired
gross neurological functioning and learning and memory deficits.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par4">We significantly broaden the mutational and clinical spectrum of<italic>CTCF</italic>-associated NDDs. Our data shed light
onto the functional role of CTCF by identifying deregulated genes and show that
Ctcf alterations result in nervous system defects in <italic>Drosophila</italic>.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>CTCF</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>
<italic>Drosophila melanogaster</italic>
</kwd>
<kwd>intellectual disability</kwd>
<kwd>chromatin organization</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id>
<institution>Deutsche
Forschungsgemeinschaft</institution>
</institution-wrap>
</funding-source>
<award-id>ZW184/1-2</award-id>
<principal-award-recipient>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id>
<institution>Deutsche
Forschungsgemeinschaft</institution>
</institution-wrap>
</funding-source>
<award-id>ZW184/3-1</award-id>
<principal-award-recipient>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id>
<institution>Deutsche
Forschungsgemeinschaft</institution>
</institution-wrap>
</funding-source>
<award-id>270949263/GRK2162</award-id>
<principal-award-recipient>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>IZKF, Medizinische Fakultät, Friedrich-Alexander-Universität
Erlangen-Nürnberg (DE)</institution>
</funding-source>
<award-id>E26</award-id>
<principal-award-recipient>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>FWO Vlaanderen</institution>
</funding-source>
<award-id>0000</award-id>
<principal-award-recipient>
<name>
<surname>Van Esch</surname>
<given-names>Hilde</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id>
<institution>Wellcome
Trust</institution>
</institution-wrap>
</funding-source>
<award-id>WT098051</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Health Innovation Challenge Fund</institution>
</funding-source>
<award-id>HICF-1009-003</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000051</institution-id>
<institution>National Human Genome
Research Institute</institution>
</institution-wrap>
</funding-source>
<award-id>UM1 HG008900</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Estonian Research Council</institution>
</funding-source>
<award-id>PUT355</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Estonian Research Council</institution>
</funding-source>
<award-id>PRG471</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Estonian Research Council</institution>
</funding-source>
<award-id>PUTJD827</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of
Health</institution>
</institution-wrap>
</funding-source>
<award-id>T32GM007748</award-id>
<principal-award-recipient>
<name>
<surname>Wojcik</surname>
<given-names>Monica H.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>ELAN-Fonds, FAU Erlangen-Nürnberg</institution>
</funding-source>
<award-id>0000</award-id>
<principal-award-recipient>
<name>
<surname>Zweier</surname>
<given-names>Christiane</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© American College of Medical Genetics and Genomics 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>INTRODUCTION</title>
<p id="Par5">CCCTC-binding factor CTCF is one of the most important chromatin
organizers in vertebrates. It is crucial for orchestrating the three-dimensional
chromatin structure by intra- and interchromosomal loop formation and by
contributing to the organization of topologically associated
domains.<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>
Additionally, it is involved in many chromatin regulating processes, including gene
regulation, blocking of heterochromatin spreading,
imprinting,<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> and X-inactivation.<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> CTCF is able to bind various
DNA motifs with different specific combinations of its 11 C2H2-type zinc
fingers<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and has over 30,000 binding sites in the human
genome.<sup><xref ref-type="bibr" rid="CR6">6</xref></sup></p>
<p id="Par6">In 2013 Gregor et al. identified a larger de novo deletion (280 kb, 8
genes), two intragenic likely gene-disruptive (LGD) variants (c.375dupT,
p.(Val126Cysfs*14); c.1186dupA, p.[Arg496Lysfs*13]) and one missense variant
(c.1699C &gt; T, p.[Arg567Trp]) in <italic>CTCF</italic> in four
individuals with variable intellectual disability (ID), microcephaly, and growth
retardation<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (mental retardation, autosomal dominant 21,
MRD21, MIM 615502). In three of these individuals RNA-sequencing was performed,
which revealed a broad deregulation of genes involved in cellular response to
extracellular stimuli.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> Since that initial report, only a few other case
studies on intragenic pathogenic <italic>CTCF</italic> variants
have been published. A de novo frameshift variant was identified in a girl with
developmental delay, short stature, severe microcephaly, heart defects, and various
other anomalies,<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> and very recently, two frameshifting and the same
missense variant as in Gregor et al.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> were reported in three Chinese individuals
with ID, feeding difficulties, and microcephaly.<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> Additionally, two larger
deletions of 1.1 and 1.6 Mb, respectively, encompassing <italic>CTCF</italic>, were identified in individuals with developmental delay and
growth impairment.<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> Further studies reported the identification of<italic>CTCF</italic> variants in large cohorts with various
clinical indications but did not provide detailed clinical
information.<sup><xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup></p>
<p id="Par7">We now report on 39 additional individuals with variants in <italic>CTCF</italic>, further delineating the mutational and clinical
spectrum of <italic>CTCF</italic>-related neurodevelopmental
disorders (NDD). By RNA-sequencing we confirm a broad deregulation of genes in five
affected individuals. By utilizing <italic>Drosophila
melanogaster</italic> we could demonstrate that Ctcf is crucial for learning
and memory in a dosage-sensitive manner, thus confirming loss of function or
haploinsufficiency as the driving force in <italic>CTCF</italic>-related NDDs.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="Sec3">
<title>Patients and patient material</title>
<p id="Par8">Personal communication with colleagues following the initial
report,<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> searching the DECIPHER
database,<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup> and using
GeneMatcher<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> enabled us to collect clinical and
mutational details on 39 individuals with variants in <italic>CTCF</italic>. Testing (for individual methods see Table <xref ref-type="media" rid="MOESM2">S1</xref>) in collaborating centers was performed
either in the setting of routine diagnostic testing without the requirement for
institutional ethics approval or within research settings approved by the
ethical review board of the respective institutions (University
Erlangen-Nuremberg, University of Tartu, UZ Leuven, Northern Ostrobothnia
Hospital District, Cambridge South REC, Republic of Ireland REC; see also
Table <xref ref-type="media" rid="MOESM2">S1</xref>). Informed consent for
publication of patient photos and for testing and for publication of mutational
and clinical data was obtained from the individuals, or their parents or legal
guardians. RNA from blood lymphocytes was collected with the PAXgene system
(PreAnalytiX, BD and Qiagen, Hombrechtikon, Switzerland) from three individuals
with missense variants and two individuals with LGD variants plus from two
individuals with unclear splice-site or nonsense variants. RNA samples from four
healthy female and four healthy male young adults were used as controls.</p>
<p id="Par9">Structural analysis for selected variants was performed as described
in the Supplementary <xref ref-type="media" rid="MOESM1">Methods</xref>.</p>
</sec>
<sec id="Sec4">
<title>Transcriptome analysis</title>
<p id="Par10">Quality control of RNA samples was performed using a Bioanalyzer
2100 (Agilent, Santa Clara, CA, USA). Library preparation was performed using
the TruSeq Stranded mRNA LT Sample Prep Kit (Illumina, San Diego, CA,
USA).</p>
<p id="Par11">Libraries were subjected to single-end sequencing (101 bp) on a
HighSeq-2500 platform (Illumina). The obtained reads were converted to .fastq
format and demultiplexed using bcl2fastq v2.17.1.14. Quality filtering was
performed using cutadapt v. 1.15;<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> then reads were mapped against the human
reference genome (Ensembl GRCh37, release 87) using the STAR aligner v.
2.5.4a,<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and a STAR genome directory created by
supplying the Ensembl gtf annotation file (release 87). Read counts per gene
were obtained using featureCounts program v. 1.6.1<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and the Ensembl gtf
annotation file. Subsequent analyses were performed using R version
3.5.0.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> In particular, differential expression
analysis was performed with the DESeq2 package
v.1.20.0.<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> Additionally, the lfc shrink function of the
apeglm package was used to control for expression changes in lowly expressed
genes.<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> Gene lists were filtered for protein coding
genes with a base mean count of at least 10. Differentially expressed (DE) genes
were identified by filtering for padj ≤0.01. DE genes with a log2foldchange
&gt;0 or &lt;0 were considered as “upregulated” and “downregulated,”
respectively. Enrichment of GO Terms among DE genes was analyzed utilizing the
PANTHER version 14.0<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> enrichment analysis tool on the Gene
Ontology<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> homepage with the following settings: test:
“Fisher’s Exact”; correction: “Calculate false discovery rate”; and GO-Slim
terms as annotation data set. A list of all expressed genes within controls and
the affected individuals was used as background.</p>
</sec>
<sec id="Sec5">
<title>Immunofluorescence and fractionation</title>
<p id="Par12">Immunofluorescence and fractionation to assess subcellular
localization of CTCF are described in detail in the Supplementary <xref ref-type="media" rid="MOESM1">Material and Methods</xref>.</p>
</sec>
<sec id="Sec6">
<title>Fly lines and conditions</title>
<p id="Par13">Flies were kept on standard food containing cornmeal, sugar, yeast,
and agar. Tissue-specific knockdown or overexpression was attained with the
UAS/GAL4 system.<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> Crosses were carried out at 28 °C to induce
knockdown and at 25 °C to induce overexpression (and knockdown for the courtship
conditioning assay). The <italic>Ctcf</italic>-RNAi line (VDRC
108857/KK) and the respective control (VDRC 60100) were obtained from the Vienna
Drosophila Resource Center (VDRC, Vienna, Austria),<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> as well as the control
(VDRC 60000) used for the hypomorphic <italic>Ctcf</italic>
mutant line (BL 21162). This line and the GAL4-driver stocks (BL 4414, <italic>actin</italic>-GAL4 for ubiquitous expression; BL 8816,<italic>D42</italic>-GAL4 for motoneurons; BL 8184,<italic>DJ757</italic>-GAL4 expressed in muscle; BL 7415,<italic>repo</italic>-GAL4 expressed in glia; BL 8765,<italic>elav</italic>-GAL4/Cyo expressed pan-neuronal) and
the control line for UAS-<italic>Ctcf</italic> (BL 24749) were
obtained from the Bloomington <italic>Drosophila</italic>
Stock Center (BDSC, Bloomington, IN, USA). The <italic>Ctcf</italic> mutant line was isogenized by backcrossing it with vdrc
60000 for at least 7 generations. UAS-<italic>Ctcf</italic>
was obtained from the Zurich ORFeome Project (FlyORF, Zurich,
Switzerland).<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> The driver lines for class IV dendritic
arborization (da) neurons (UAS-<italic>Dcr</italic>-2;<italic>477</italic>-GAL4,UAS-<italic>mCD8::GFP</italic>;<italic>ppk</italic>-GAL4/Tm3sb), mushroom body (UAS-Dcr-2;247-GAL4), and
pan-neuronal expression (<italic>elav</italic>-GAL4;<italic>elav</italic>-GAL4) were assembled from colleagues. We
confirmed <italic>Ctcf</italic> knockdown and overexpression
by quantitative reverse transcription polymerase chain reaction (RT-PCR)
(Fig. <xref ref-type="media" rid="MOESM1">S1</xref>).</p>
</sec>
<sec id="Sec7">
<title>Analyses of larval neuromuscular junctions and dendritic arborization
neurons</title>
<p id="Par14">Analysis of type 1b neuromuscular junctions (NMJs) of larval muscle
4 as well as analysis of dendritic arborization (da) neurons were performed as
described previously<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (for detailed description, see Supplementary
<xref ref-type="media" rid="MOESM1">Methods</xref>).</p>
</sec>
<sec id="Sec8">
<title>Bang sensitivity and climbing assay</title>
<p id="Par15">Climbing behavior and bang sensitivity testing was performed as
described elsewhere<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and as in more detail in the Supplementary
<xref ref-type="media" rid="MOESM1">Methods</xref> upon pan-neuronal
(<italic>elav</italic>-GAL4), motoneuronal (<italic>D42</italic>-GAL4), and/or glial (<italic>repo</italic>-GAL4) manipulation.</p>
</sec>
<sec id="Sec9">
<title>Courtship conditioning paradigm</title>
<p id="Par16">The courtship conditioning paradigm assays were performed as
described previously<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> with the mutant <italic>Ctcf</italic> line and upon mushroom body (UAS-<italic>Dcr</italic>-2;<italic>247</italic>-GAL4) specific
knockdown or overexpression of <italic>Ctcf</italic>. Flies
were kept at 25 °C and 70% humidity at a 12:12 light–dark cycle. Virgin males
were trained individually by pairing them with premated females. Learning and
short-term memory were tested immediately or 1 hour after a training period of
1 hour, respectively. Long-term memory was tested 24 hours after a training
period of 14 hours. The courtship index (CI), the percentage of time each male
spent courting a nonreceptive female, was manually assessed from 10-minute
movies. By comparing the CI of naïve and trained males a learning index was
calculated: LI = (CInaive − CItrained) / CInaive. Differences between LIs of
control and mutant flies were statistically compared by a randomization test
with 10,000 bootstrap replicates with a custom R
script.<sup><xref ref-type="bibr" rid="CR30">30</xref></sup></p>
</sec>
</sec>
<sec id="Sec10" sec-type="results">
<title>RESULTS</title>
<sec id="Sec11">
<title>Mutational spectrum encompasses large deletions, likely gene-disruptive,
and missense variants</title>
<p id="Par17">The identified aberrations in <italic>CTCF</italic> include two large deletions in 16q22.1, encompassing<italic>CTCF</italic> plus 26 (arr[GRCh37]
16q22.1[67588276_68173459]×1) or 43 (arr[GRCh37] 16q22.1[67345851_68899546]×1)
neighboring genes, respectively. In addition, we identified six frameshifting
variants (including a deletion of exon 8); two nonsense variants; two variants
in the splice acceptor site of exon 4, for one of which in-frame deletion of
exon 4 was demonstrated (Fig. <xref ref-type="media" rid="MOESM1">S2a,b</xref>);
and 20 different missense variants (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Table <xref ref-type="media" rid="MOESM2">S1</xref>).
Regarding the latter, seven amino acid residues were recurrently affected:
p.Arg342 was twice exchanged to Cys and to His in three individuals from one
family; p.Arg368 was altered twice to Cys and once to His; p.His373 once to Asp
and once to Pro; and p.(Arg377His), p.(Pro378Leu), and p.(Arg448Gln) were
observed twice, respectively (Fig. <xref ref-type="fig" rid="Fig1">1</xref>,
Table <xref ref-type="media" rid="MOESM2">S1</xref>). p.(Arg567Trp) has been
reported in two individuals previously.<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup> All missense variants were located in
exons encoding one of the 11 zinc fingers. Of note, the majority (6/8) of LGD
variants were located in exons 3 and 4, just upstream of or at the start of the
zinc finger domains. Most variants were shown to be de novo. In six cases one or
both parents were not available for testing, and two cases were familial with
the variant being transmitted from a presumably healthy mother to her affected
son or from an affected father to his twin children. In the first family, the
nonsense variant p.(Arg654*) was located rather C-terminal, therefore we
confirmed nonsense-mediated messenger RNA (mRNA) decay by RT-PCR
(Fig. <xref ref-type="media" rid="MOESM1">S2c</xref>). Language barrier
prevented a proper evaluation of the mother’s cognitive capabilities, and though
not indicated by the read distribution in DNA from blood, a tissue-specific
mosaicism in her could not be excluded. In the second family, structural
analysis of the p.(Arg342His) variant indicated a negative effect on CTCF
stability, mildly weaker compared with the p.(Arg342Cys) variant observed de
novo in two individuals (Fig. <xref ref-type="media" rid="MOESM1">S3a–c</xref>).
One missense variant was mosaic with an alternative allele frequency of
approximately 13%. Apart from the previously published p.(Arg567Trp) variant,
all missense variants were novel, affected highly conserved amino acids, and
were predicted to be deleterious by several in vitro prediction programs
(Table <xref ref-type="media" rid="MOESM2">S1</xref>). The p.(Arg368His)
variant occurred once in gnomAD, while all other variants were absent. Several
residues of identified missense variants, i.e., p.(Arg278Leu), p.(Asp529Asn),
p.(Arg567Trp), carried one other amino acid exchange in gnomAD
(Table <xref ref-type="media" rid="MOESM2">S1</xref>). Comparing the
recurrent pathogenic variant p.(Arg567Trp) with p.(Arg567Gln) from gnomAD by
structural modeling indicated an only mild impairment of polar interaction with
the phosphate backbone of the DNA for the Arg567Gln variant, while the Arg567Trp
variant resulted in a significantly reduced binding affinity (Fig. <xref ref-type="media" rid="MOESM1">S3d–f</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>Variants identified in</bold><bold><italic>CTCF</italic></bold>. <bold>a</bold> Schematic drawing of the <italic>CTCF</italic> gene with known and novel
variants. Noncoding exons are displayed in light gray, coding
exons in medium gray, and exons encoding zinc fingers in dark
gray. <bold>b</bold> Schematic drawing of
the CTCF protein. Missense or in-frame variants are displayed
above and likely gene-disruptive variants below the scheme.
Nonbold variants and p.(Arg567Trp) were published previously
with or *without clinical details.<sup><xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup> Underlined variants are
recurrent. All identified pathogenic or likely pathogenic
in-frame or missense variants affect one of the 11 zinc finger
domains.</p></caption><graphic id="d29e1989" xlink:href="41436_2019_585_Fig1_HTML"></graphic></fig></p>
<p id="Par18">According to the guidelines of the American College of Medical
Genetics and Genomics (ACMG), variants in 36 individuals were considered as
pathogenic or likely pathogenic, while three variants (p.[Arg278Leu],
p.[Ser360Arg], p.[Asp529Asn]) remained of unknown significance due to an
atypical phenotype or lack of segregation testing (Table <xref ref-type="media" rid="MOESM2">S1</xref>). While structural modeling for the
p.(Asp529Asn) variant indicated that it might be tolerated without significantly
affecting the CTCF structure (Fig. <xref ref-type="media" rid="MOESM1">S3d</xref>), it suggested a decreased DNA-binding affinity for the
p.(Arg278Leu) variant (Fig. <xref ref-type="media" rid="MOESM1">S3g–h</xref>) and
impaired DNA base pair recognition for the p.(Ser360Arg) variant
(Fig. <xref ref-type="media" rid="MOESM1">S3i–k</xref>).</p>
</sec>
<sec id="Sec12">
<title>Clinical spectrum is highly variable</title>
<p id="Par19">All but one (due to young age) of the 36 affected individuals with
intragenic <italic>CTCF</italic> aberrations classified as
pathogenic or likely pathogenic presented with developmental delay and/or ID.
Cognitive impairment was extremely variable, ranging from learning difficulties,
normal IQ, and attending mainstream school or graduating from college in seven
individuals to severe ID in three individuals. Walking age ranged from 12 months
to three years, and age of first words from 12–18 months to lack of speech at
age 12 years. Older individuals with active speech usually spoke in sentences.
Intrauterine growth restriction or low birth measurements were reported in ten
individuals, and failure to thrive or feeding difficulties, often requiring tube
feeding, occurred in 23 individuals. Postnatal short stature was noted in 6 and
(borderline) microcephaly in 12 individuals. Tall stature and/or obesity were
observed in three individuals. Behavioral anomalies such as autistic features,
attention deficit and hyperactivity or aggressivity were common and reported in
24 individuals. Cardiac defects occurred in 11 individuals, and palatal
anomalies such as cleft palate or high palate were present in 12 individuals.
Conductive and/or sensorineuronal hearing loss were reported in 10 and vision
anomalies in 15 individuals. Recurrent urinary tract, airway, or middle ear
infections were reported in 14 individuals. Febrile or nonfebrile seizures or
teeth anomalies occurred in four individuals, respectively. Furthermore,
nonspecific magnetic resonance image (MRI) anomalies and minor skeletal
anomalies were reported (Table <xref ref-type="table" rid="Tab1">1</xref>,
Table <xref ref-type="media" rid="MOESM2">S1</xref>). Minor facial
dysmorphisms were frequently noted but did not point to a recognizable, typical
facial gestalt (Fig. <xref ref-type="fig" rid="Fig2">2</xref>,
Table <xref ref-type="media" rid="MOESM2">S1</xref>). Individuals 1 and 2
with larger deletions presented with a similar phenotype with mild to moderate
ID and without growth and other major abnormalities (Table <xref ref-type="media" rid="MOESM2">S1</xref>). Individual 1 carrying the 1.5-Mb deletion
is at high risk of developing gastric cancer because <italic>CDH1</italic> maps within the deleted fragment. No obvious
genotype–phenotype correlations between LGD and missense variants or between
intragenic variants and larger deletions could be delineated (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Main clinical features in individuals with pathogenic or
likely pathogenic variants in <italic>CTCF</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>LGD variants <italic>n</italic> = 8</th><th>Missense/in-frame variants <italic>n</italic> = 26</th><th>Published variants<sup>a</sup><italic>n</italic> = 7</th><th>Total intragenic</th><th>Large deletions<sup>b</sup><italic>n</italic> = 5</th></tr></thead><tbody><tr><td>IUGR/SGA</td><td>2/8</td><td>8/25</td><td>5/7</td><td>37%</td><td>0/5</td></tr><tr><td>Feeding difficulties/FTT</td><td>6/8</td><td>17/23</td><td>7/7</td><td>78%</td><td>3/5</td></tr><tr><td>Short stature</td><td>1/8</td><td>5/25</td><td>5/7</td><td>27%</td><td>2–3/5<sup>c</sup></td></tr><tr><td>Microcephaly</td><td>3/7</td><td>7–9/22</td><td>7/7</td><td>52%</td><td>2–3/5<sup>c</sup></td></tr><tr><td>Walking age</td><td>14–32 months</td><td>12–36 months</td><td>14 months to &gt;3.5 years</td><td></td><td>23 months to &gt;4.2 years</td></tr><tr><td>Age first words</td><td>12 months–4 years</td><td>12 mo—no speech</td><td>12 months to &gt;3.5 years</td><td></td><td>18 months to &gt;4.2 years</td></tr><tr><td>Unspecified DD/ID</td><td>0/8</td><td>7/25</td><td>1/7</td><td>20%</td><td>0/5</td></tr><tr><td>Mild/borderline DD/ID</td><td>5/8</td><td>9/25</td><td>3/7</td><td>42%</td><td>2/5</td></tr><tr><td>Moderate ID</td><td>3/8</td><td>6/25</td><td>1/7</td><td>25%</td><td>3/5</td></tr><tr><td>Severe ID</td><td>0/8</td><td>3/25</td><td>2/7</td><td>12%</td><td>0/5</td></tr><tr><td>Behavioral anomalies</td><td>5/6</td><td>19/23</td><td>4/7</td><td>77%</td><td>4/5</td></tr><tr><td>Seizures</td><td>1/8</td><td>3/23</td><td>0/7</td><td>10%</td><td>1/5</td></tr><tr><td>Cardiac defects</td><td>2/6</td><td>9/23</td><td>3/7</td><td>38%</td><td>0/5</td></tr><tr><td>Palatal anomalies</td><td>3/8</td><td>9/23</td><td>2/7</td><td>36%</td><td>0/5</td></tr><tr><td>Hearing loss</td><td>0/8</td><td>10/23</td><td>0/7</td><td>26%</td><td>1/5</td></tr><tr><td>Vision anomalies</td><td>6/8</td><td>9/19</td><td>6/7</td><td>61%</td><td>3/5</td></tr><tr><td>Recurrent infections</td><td>2/7</td><td>12/23</td><td>3/7</td><td>45%</td><td>1/5</td></tr></tbody></table><table-wrap-foot><p><italic>DD</italic> developmental delay,<italic>FTT</italic> failure to thrive,<italic>ID</italic> intellectual
disability<italic>,</italic><italic>IUGR</italic> intrauterine growth
restriction, <italic>LGD</italic> likely
gene-disruptive, <italic>SGA</italic> small for
gestational age.</p><p><sup>a</sup>See refs.
<sup><xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref></sup>.</p><p><sup>b</sup>Two patients from this study
plus three published ones.<sup><xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR10">10</xref></sup></p><p><sup>c</sup>One patient was treated with
growth hormones.</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p><bold>Facial gestalt of individuals with
pathogenic variants in</bold><bold><italic>CTCF</italic></bold>. Note minor facial
dysmorphism such as a long face (e.g., I5, I8, I11, I27), a
prominent forehead (e.g., I4, I8, I18, I33, I35) or a bulbous
nasal tip and long palpebral fissures in several individuals,
but no overall distinct, recognizable facial
gestalt.</p></caption><graphic id="d29e2469" xlink:href="41436_2019_585_Fig2_HTML"></graphic></fig></p>
<p id="Par20">Individuals 38 and 39 with variants of unknown significance due to
lack of parental samples also presented with similar phenotypes, while in
contrast, individual 37 with an unclear de novo variant did not show any
developmental delay or cognitive impairment, but showed immune deficiency.
Although recurrent infections are common in individuals with <italic>CTCF</italic> variants, it remains unclear if the severe
proneness to infections in individual 37 might be caused by the <italic>CTCF</italic> variant alone.</p>
</sec>
<sec id="Sec13">
<title>Missense variants in <italic>CTCF</italic> do not affect
its subcellular localization</title>
<p id="Par21">To investigate a possible effect of missense variants on the
subcellular localization and DNA-binding capacities of CTCF, we performed
immunofluorescence upon overexpression of eight different mutant <italic>CTCF</italic> constructs in HeLa cells, respectively. All
tested variants resulted in a nuclear localization with traces of protein in the
cytosol, thus closely resembling wild-type CTCF and indicating that missense
variants do not alter gross subcellular localization or distribution
(Fig. <xref ref-type="media" rid="MOESM1">S4a</xref>). Fractionating
lymphoblastoid cell lines from two affected individuals into subcellular
compartments did not indicate differences in the distribution of mutant CTCF
compared with a healthy control (Fig. <xref ref-type="media" rid="MOESM1">S4b</xref>).</p>
</sec>
<sec id="Sec14">
<title>Transcriptome analysis reveals a broad deregulation of genes</title>
<p id="Par22">RNA-sequencing on RNA from blood cells of five individuals with
pathogenic <italic>CTCF</italic> variants and eight healthy
controls confirmed similarly decreased <italic>CTCF</italic>
expression for the two LGD variants (log2 fold changes = −0.94 and −1.07,
respectively), indicating nonsense-mediated mRNA decay as previously confirmed
for two other frameshifting variants.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> In accordance with previous
findings,<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> at least two of the three individuals with
missense variants had only mildly decreased <italic>CTCF</italic> levels compared with controls (log2 fold changes
p.[Arg368Cys]: −0.83; p.[Arg342Cys]: −0.02; p.[Glu336Gln]: −0.2)
(Table <xref ref-type="media" rid="MOESM3">S2</xref>). Affected individuals
clustered with each other as did controls regarding differentially expressed
genes (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>Transcriptome analysis
in</bold><bold><italic>CTCF</italic></bold><bold>-deficient individuals.</bold><bold>a</bold> Heatmap displaying the 3828
differentially expressed genes between five affected individuals
and eight healthy controls and depicting the expression
similarity between individuals with corrected <italic>p</italic> value &lt;0.01; 2161 genes were
downregulated and 1667 genes were upregulated in the affected
individuals. Individuals are clustered by Euclidean distance,
and genes are sorted by adjusted <italic>p</italic> value. Blue, downregulated; red, upregulated.<bold>b</bold>, <bold>c</bold> Gene Ontology (GO) term analysis on <bold>b</bold> downregulated and <bold>c</bold> upregulated genes depicting the top
five GO terms for biological processes <italic>FDR</italic> false discovery rate.</p></caption><graphic id="d29e2562" xlink:href="41436_2019_585_Fig3_HTML"></graphic></fig></p>
<p id="Par23">There were 3828 genes that were differentially expressed between
affected individuals and controls; 1667 were upregulated and 2161 were
downregulated (Table <xref ref-type="media" rid="MOESM3">S2</xref>). Regarding
differentially expressed genes, affected individuals behaved more similarly
within their mutational group (likely gene-disruptive variants vs. missense
variants) (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). Nevertheless, we
found significant overlap between differentially expressed genes in the two
individuals with LGD variants and the three individuals with missense variants
(<italic>p</italic> &lt; 1 × 10<sup>−16</sup>, hypergeometric
test), indicating similar consequences of various types of pathogenic variants
on gene regulation.</p>
<p id="Par24">To investigate the role of differentially expressed genes in
neurodevelopmental function and dysfunction, we calculated enrichment of known
NDD-associated genes (SysID, status November 2018, Table <xref ref-type="media" rid="MOESM3">S2</xref>) among the deregulated genes. This was
significant for both the upregulated and the downregulated genes (<italic>p</italic> = 4.13 × 10<sup>−4</sup> and
2.2 × 10<sup>−16</sup>, respectively, chi-square
test).</p>
<p id="Par25">Downregulated genes were enriched for Gene Ontology (GO) terms such
as transcription-related processes and regulation of biological processes
(Fig. <xref ref-type="fig" rid="Fig3">3b</xref>, Table <xref ref-type="media" rid="MOESM3">S2</xref>). Upregulated genes were enriched for
translational processes and ribonucleoprotein and ribosomal processes
(Fig. <xref ref-type="fig" rid="Fig3">3c</xref>, Table <xref ref-type="media" rid="MOESM3">S2</xref>).</p>
</sec>
<sec id="Sec15">
<title><italic>Ctcf</italic> dosage alterations in <italic>Drosophila melanogaster</italic> impair gross neurological
functioning and complex learning and memory behavior</title>
<p id="Par26">Given that <italic>CTCF</italic>
haploinsufficiency leads to disease, we utilized <italic>Drosophila melanogaster</italic> as a model organism to investigate the
consequences of altered <italic>Ctcf</italic> dosage on
nervous system development and function. First, we investigated whether altered
levels of <italic>Ctcf</italic> resulted in altered
development and morphology of larval neuromuscular junctions (NMJs). These large
synapses represent an established model system for vertebrate glutamatergic
synapses.<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> We did not observe any significant or
consistent alterations regarding NMJ area, length, or number of synaptic boutons
or active zones in the mutant, or upon pan-neuronal knockdown or overexpression
(Fig. <xref ref-type="media" rid="MOESM1">S5a–c</xref>). As a significant
decrease of dendritic branching has been reported in a conditional Ctcf knockout
mouse,<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> we examined the large dendritic arborization
(da) neurons in <italic>Drosophila</italic> larvae. We did not
observe any significant alterations regarding number or length of dendrites upon
knockdown of Ctcf in these neurons compared with controls, while overexpressing
Ctcf resulted in a mild increase in total length (Fig. <xref ref-type="media" rid="MOESM1">S6</xref>). Also testing for bang sensitivity, a model
for seizure susceptibility,<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> did not result in aberrant phenotypes
upon pan-neuronal knockdown or overexpression or in the mutant condition
(Fig. <xref ref-type="media" rid="MOESM1">S5d–f</xref>).</p>
<p id="Par27">The impact of <italic>Ctcf</italic> dosage
alteration on gross neurological function was addressed with the climbing assay,
which is based on the negative geotaxis, an innate behavior to climb up after
being tapped down.<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> Flies with knockdown of <italic>Ctcf</italic> in all neurons or specifically in motoneurons
showed a significant impairment in their climbing abilities while it was not
altered in flies with glial knockdown. Pan-neuronal overexpression of Ctcf did
not result in impaired climbing behavior, but overexpression in motoneurons or
particularly in glia cells did (Fig. <xref ref-type="fig" rid="Fig4">4a,
c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>Impact of</bold><bold><italic>Ctcf</italic></bold><bold>dosage alteration on fly gross
neurological functioning and learning and memory.</bold><bold>a</bold>–<bold>c</bold> Flies with knockdown of <italic>Ctcf</italic> in <bold>a</bold> motoneurons and <bold>b</bold> all neurons but not in <bold>c</bold> glia showed significant locomotor impairment
in the climbing assay. Pan-neuronal overexpression <bold>b</bold> had no effect, but <bold>c</bold> glial and <bold>a</bold> motoneuronal driven overexpression of<italic>Ctcf</italic> resulted in
significant locomotor impairment. The numbers below the columns
represent the samples in groups of ten flies tested per
genotype. <bold>d</bold> In the courtship
conditioning paradigm, the hypomorphic <italic>Ctcf</italic> mutant line showed highly significant
impairment of learning (L) and short-term memory (STM) and
significant impairment of long-term memory (LTM). <bold>e</bold> In accordance, mushroom body–driven
(UAS-<italic>Dcr-2</italic>;<italic>247</italic>-GAL4) knockdown of <italic>Ctcf</italic> resulted in significantly
reduced short-term memory (STM). Similar tendencies were
observed for L and LTM, but not reaching significance. <bold>f</bold> Overexpression of <italic>Ctcf</italic> in the mushroom body did not
result in a significant effect on L and STM, but in a
significant impairment of long-term memory. Graphs display mean
values of the number of animals indicated below the columns per
genotype from at least three independent test days. Differences
between learning indexes of control and mutant flies were
statistically compared by a randomization test with 10,000
bootstrap replicates with a custom R
script.<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> Error bars depict SEM.
Asterisks indicate statistical significance (<italic>p</italic> value: *≤0.05, **≤0.01,
***≤0.001).</p></caption><graphic id="d29e2744" xlink:href="41436_2019_585_Fig4_HTML"></graphic></fig></p>
<p id="Par28">Finally, we tested the consequences of <italic>Ctcf</italic> dosage alterations on complex learning and memory processes
utilizing the courtship condition paradigm.<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> Ubiquitous low levels
of <italic>Ctcf</italic> in the hypomorphic mutant as well as
knockdown of <italic>Ctcf</italic> specifically in the
mushroom body, the fly center for learning and memory, resulted in significantly
impaired learning and short-term memory compared with the respective controls.
Overexpression of <italic>Ctcf</italic> in the mushroom body
did not result in significantly altered learning and short-term memory, but in
significantly reduced long-term memory (Fig. <xref ref-type="fig" rid="Fig4">4d–f</xref>), indicating a crucial role of correct <italic>Ctcf</italic> dosage for complex learning and memory
processes.</p>
</sec>
</sec>
<sec id="Sec16" sec-type="discussion">
<title>DISCUSSION</title>
<p id="Par29">By assembling data on additional 36 individuals with pathogenic or
likely pathogenic variants in <italic>CTCF</italic> we
considerably contribute to the delineation of the mutational and clinical spectrum
of <italic>CTCF</italic>-associated NDDs. The phenotype associated
with <italic>CTCF</italic> aberrations is highly variable. All
individuals presented with developmental delay and/or a variable degree of learning
or cognitive difficulties, extending into (low) normal IQ ranges. The mild end of
the phenotypic spectrum is reflected by two familial cases in our cohort. As also
true for other, potentially mild NDDs, autosomal dominant inheritance has to be
considered, particularly in trio exome approaches when primarily searching for de
novo variants. Our observations might also imply that due to a possibly very mild
phenotype or incomplete penetrance, very rare presence of a variant in public
databases such as ExAC or gnomAD is not necessarily an exclusion criterion for its
pathogenicity.</p>
<p id="Par30">Feeding anomalies and failure to thrive, as well as behavioral
anomalies, were the most frequently associated symptoms. In addition, postnatal
short stature and microcephaly, as well as a whole range of different birth
malformations and anomalies, including cardiac defects, cleft palate, hearing loss,
vision anomalies, recurrent infections, and muscular hypotonia were noted. Despite
this wide range of anomalies and despite noticing minor facial dysmorphism in many
of the affected individuals, we consider the phenotype not sufficiently distinct as
to be clinically recognizable.</p>
<p id="Par31">Previous studies have pointed to haploinsufficiency of <italic>CTCF</italic> as the main disease-causing
mechanism.<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup> An earlier hypothesis
suggested a possible genotype–phenotype correlation between missense and LGD
variants but was based on a very small number of affected
individuals.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> Our extensive follow-up study does not indicate
any clear correlation between nature and location of variants and clinical
presentation. Furthermore, differentially expressed genes significantly overlapped
between individuals with either missense or LGD variants, and we did not observe
effects on gene regulation or gross subcellular localization, though subtle changes
would still be possible. Both the previous and all newly identified missense
variants are located within several of the 11 zinc finger domains, most likely
resulting in loss of function by impaired DNA binding, as also indicated by
structural modeling for several variants. Of note, the neurodevelopmental phenotype
in individuals with larger deletions encompassing <italic>CTCF</italic> is not markedly different or more severe than in individuals
with intragenic missense or LGD variants. This indicates that no other
dosage-sensitive genes relevant for neurodevelopment are located nearby and further
implies (functional) haploinsufficiency of <italic>CTCF</italic>
resulting from all kinds of pathogenic variants as the most likely disease
mechanism.</p>
<p id="Par32">Considering the crucial and extremely broad role of CTCF in chromatin
organization and regulation it is still very surprising that its haploinsufficiency
or loss of function can result in such a relatively mild phenotype. Nevertheless,
transcriptome analysis showed a broad deregulation of genes. In line with a previous
report<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and with gene expression profiles in conditional
knockout mice,<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> we detected more downregulated than upregulated
genes, further supporting a primarily activating role of CTCF for target genes
involved in the pathomechanism of <italic>CTCF</italic>-related
disorders. Differentially expressed genes were enriched for biological processes and
for general ribosomal and transcriptional processes. They were also enriched for
known NDD-associated genes, emphasizing the role of CTCF in neurodevelopmental
function and dysfunction. CTCF-deficient mice die in early implantation
stages,<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> highlighting its essential role in embryonic
development. Conditional knockout in postmitotic projection neurons or in the
developing brain resulted in postnatal growth retardation, abnormal behavior,
dendritic arborization anomalies, and death within one month or in deficits in
neuroprogenitor differentiation resulting in microcephaly and perinatal death,
respectively.<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> These observations support a crucial role of
CTCF in neurodevelopment, but the early lethality prevents investigating the role of
CTCF for learning and memory processes in vivo. We chose <italic>Drosophila</italic> as a model because existence of a viable hypomorphic
mutant and tissue-specific knockdown and overexpression could circumvent lethality.
In contrast to observations of reduced dendritic arborization and spine numbers in
mice,<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> we did not observe alterations in <italic>Drosophila</italic> larval dendritic arborization neurons or
neuromuscular junctions upon knockdown of <italic>Ctcf</italic>
and only mildly significant changes of dendritic length upon overexpression. Such
discordant findings might be related to the fact that, in contrast to mammals,<italic>Drosophila</italic> possesses three other insulator
binding proteins next to Ctcf that could take over some of the Ctcf
functions.<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> This might be the reason why Ctcf is less
crucial for setting up genome organization or global gene expression during<italic>Drosophila</italic> embryogenesis and development,
despite its many binding sites throughout the fly genome.<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup> In accordance with a more important role in
adult flies<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> we observed climbing deficits upon pan-neuronal
or motoneuronal knockdown and upon motoneuronal and glial overexpression. The marked
phenotype upon glial overexpression might point to a so-far underestimated role of
Ctcf in glia, but would require further experimental follow-up. In accordance with
cognitive deficits in humans with pathogenic <italic>CTCF</italic>
variants, we observed learning and memory deficits in the hypomorphic mutant line
and upon mushroom body–specific knockdown or overexpression. These observations
confirm the importance of proper <italic>Ctcf/CTCF</italic> dosage
for learning and memory processes.</p>
<p id="Par33">In summary, our study extensively broadens the clinical and mutational
spectrum of <italic>CTCF</italic>-related NDDs. A high number of
deregulated genes from transcriptome analyses and gross neurological as well as
learning and memory deficits in <italic>Drosophila
melanogaster</italic> provide insights into the role of proper CTCF/Ctcf
dosage for postnatal neurological and cognitive function and dysfunction.</p>
<sec id="Sec17">
<title>URLs</title>
<p id="Par34">Gene Ontology <ext-link ext-link-type="uri" xlink:href="http://geneontology.org/">http://geneontology.org/</ext-link> Homologene <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/homologene">https://www.ncbi.nlm.nih.gov/homologene</ext-link> OMIM <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link> PANTHER <ext-link ext-link-type="uri" xlink:href="http://pantherdb.org/">http://pantherdb.org/</ext-link> Primer3 <ext-link ext-link-type="uri" xlink:href="http://primer3.ut.ee/">http://primer3.ut.ee/</ext-link> SysID database <ext-link ext-link-type="uri" xlink:href="https://sysid.cmbi.umcn.nl/">https://sysid.cmbi.umcn.nl/</ext-link> UCSC Genome Browser <ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/">https://genome.ucsc.edu/</ext-link></p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec18">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41436_2019_585_MOESM1_ESM.docx"><caption><p>Supplementary File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41436_2019_585_MOESM2_ESM.xlsx"><caption><p>Supplementary TableS1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41436_2019_585_MOESM3_ESM.xlsx"><caption><p>Supplementary TableS2</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note:</bold> Springer Nature remains
neutral with regard to jurisdictional claims in published maps and institutional
affiliations.</p>
</fn>
<fn>
<p>These authors contributed equally: Hilde Van Esch, Christiane
Zweier</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>The online version of this article (10.1038/s41436-019-0585-z) contains supplementary material, which is available to authorized
users.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank all individuals and families for participating in this study. We
especially thank Laila Distel and Christine Suchy for excellent technical
assistance; André Reis, Arif Ekici, and Fulvia Ferrazzi at the next-generation
sequencing core facility at the Institute of Human Genetics in Erlangen; and Felix
Engel for help with the confocal microscope, which was supported by the German
Research Foundation (INST 410/91-1 FUGG). C.Z. is supported by grants from the
German Research Foundation (ZW184/1-2, ZW184/3-1, and 270949263/GRK2162) and by the
Interdisciplinary Center for Clinical Research in Erlangen (E26 and ELAN-Fonds).
H.V.E. is a clinical investigator of FWO Vlaanderen. K.Õ. and S.P. received support
from Estonian Research Council grants PUT355, PRG471, and PUTJD827. M.H.W. is
supported by T32GM007748. This study makes use of data generated by the DECIPHER
community. Funding for the project was provided by the Wellcome Trust. The DDD Study
presents independent research commissioned by the Health Innovation Challenge Fund
(grant number HICF-1009-003), a parallel funding partnership between Wellcome and
the Department of Health, and the Wellcome Sanger Institute (grant number WT098051).
The research team acknowledges the support of the National Institute for Health
Research, through the Comprehensive Clinical Research Network. The Broad Center for
Mendelian Genomics (UM1 HG008900) is funded by the National Human Genome Research
Institute with supplemental funding provided by the National Heart, Lung, and Blood
Institute under the Trans-Omics for Precision Medicine (TOPMed) program and the
National Eye Institute. Please also see Supplementary <xref ref-type="media" rid="MOESM1">Acknowledgements</xref>.</p>
</ack>
<notes notes-type="COI-statement">
<title>Disclosure</title>
<p id="Par35">The authors declare no conflicts of interest.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerasimova</surname>
<given-names>TI</given-names>
</name>
<name>
<surname>Byrd</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Corces</surname>
<given-names>VG</given-names>
</name>
</person-group>
<article-title>A chromatin insulator determines the nuclear
localization of DNA</article-title>
<source/>Mol Cell
          <year>2000</year>
<volume>6</volume>
<fpage>1025</fpage>
<lpage>1035</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(00)00101-5</pub-id>
<pub-id pub-id-type="pmid">11106742</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dadon</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>BE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>3D chromosome regulatory landscape of human
pluripotent cells</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>18</volume>
<fpage>262</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2015.11.007</pub-id>
<pub-id pub-id-type="pmid">26686465</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Felsenfeld</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Methylation of a CTCF-dependent boundary controls
imprinted expression of the Igf2 gene</article-title>
<source/>Nature
          <year>2000</year>
<volume>405</volume>
<fpage>482</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1038/35013100</pub-id>
<pub-id pub-id-type="pmid">10839546</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Davidow</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>CTCF, a candidate trans-acting factor for
X-inactivation choice</article-title>
<source/>Science.
          <year>2002</year>
<volume>295</volume>
<fpage>345</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1126/science.1065982</pub-id>
<pub-id pub-id-type="pmid">11743158</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klenova</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>HF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CTCF, a conserved nuclear factor required for
optimal transcriptional activity of the chicken c-myc gene, is an
11-Zn-finger protein differentially expressed in multiple
forms</article-title>
<source/>Mol Cell Biol.
          <year>1993</year>
<volume>13</volume>
<fpage>7612</fpage>
<lpage>7624</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.13.12.7612</pub-id>
<pub-id pub-id-type="pmid">8246978</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>CTCFBSDB: a CTCF-binding site database for
characterization of vertebrate genomic insulators</article-title>
<source/>Nucleic Acids Res
          <year>2008</year>
<volume>36</volume>
<issue>Database issue</issue>
<fpage>D83</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">17981843</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kouwenhoven</surname>
<given-names>EN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in the genome organizer CTCF cause
intellectual disability</article-title>
<source/>Am J Hum Genet
          <year>2013</year>
<volume>93</volume>
<fpage>124</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.05.007</pub-id>
<pub-id pub-id-type="pmid">23746550</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastaki</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a novel CTCF mutation responsible
for syndromic intellectual disability—a case report</article-title>
<source/>BMC Med Genet
          <year>2017</year>
<volume>18</volume>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-017-0429-0</pub-id>
<pub-id pub-id-type="pmid">28619046</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Three additional de novo CTCF mutations in Chinese
patients help to define an emerging neurodevelopmental
disorder</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <year>2019</year>
<volume>181</volume>
<fpage>218</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="pmid">30893510</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kawamura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nakabayashi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CTCF deletion syndrome: clinical features and
epigenetic delineation</article-title>
<source/>J Med Genet
          <year>2017</year>
<volume>54</volume>
<fpage>836</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2017-104854</pub-id>
<pub-id pub-id-type="pmid">28848059</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pammi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saronwala</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Use of exome sequencing for infants in intensive
care units: ascertainment of severe single-gene disorders and effect on
medical management</article-title>
<source/>JAMA Pediatr
          <year>2017</year>
<volume>171</volume>
<fpage>e173438</fpage>
<pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.3438</pub-id>
<pub-id pub-id-type="pmid">28973083</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Retterer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Juusola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical application of whole-exome sequencing
across clinical indications</article-title>
<source/>Genet Med
          <year>2016</year>
<volume>18</volume>
<fpage>696</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.148</pub-id>
<pub-id pub-id-type="pmid">26633542</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo coding variants are strongly associated with
Tourette disorder</article-title>
<source/>Neuron
          <year>2017</year>
<volume>94</volume>
<fpage>486</fpage>
<lpage>99 e489</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.024</pub-id>
<pub-id pub-id-type="pmid">28472652</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Deciphering Developmental Disorders
Study.</collab>
</person-group>
<article-title>Prevalence and architecture of de novo mutations in
developmental disorders</article-title>
<source/>Nature
          <year>2017</year>
<volume>542</volume>
<fpage>433</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1038/nature21062</pub-id>
<pub-id pub-id-type="pmid">28135719</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firth</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bevan</surname>
<given-names>AP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DECIPHER: Database of Chromosomal Imbalance and
Phenotype in Humans Using Ensembl Resources</article-title>
<source/>Am J Hum Genet
          <year>2009</year>
<volume>84</volume>
<fpage>524</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2009.03.010</pub-id>
<pub-id pub-id-type="pmid">19344873</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobreira</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schiettecatte</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>GeneMatcher: a matching tool for connecting
investigators with an interest in the same gene</article-title>
<source/>Hum Mutat
          <year>2015</year>
<volume>36</volume>
<fpage>928</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22844</pub-id>
<pub-id pub-id-type="pmid">26220891</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cutadapt removes adapter sequences from
high-throughput sequencing reads</article-title>
<source/>EMBnetJournal
          <year>2011</year>
<volume>17</volume>
<fpage>10</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STAR: ultrafast universal RNA-seq
aligner</article-title>
<source/>Bioinformatics
          <year>2013</year>
<volume>29</volume>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
<pub-id pub-id-type="pmid">23104886</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>featureCounts: an efficient general purpose program
for assigning sequence reads to genomic features</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>923</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
<pub-id pub-id-type="pmid">24227677</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>R Core Team.</collab>
</person-group>
<source/>R: a language and environment for statistical computing
          <year>2015</year>
<publisher-loc>Vienna, Austria.</publisher-loc>
<publisher-name>R Foundation for Statistical Computing</publisher-name>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion
for RNA-seq data with DESeq2</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
<pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Anqi</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>Joseph G</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>Michael I</given-names>
</name>
</person-group>
<article-title>Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences</article-title>
<source/>Bioinformatics
          <year>2018</year>
<volume>35</volume>
<issue>12</issue>
<fpage>2084</fpage>
<lpage>2092</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bty895</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruganujan</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PANTHER version 11: expanded annotation data from
Gene Ontology and Reactome pathways, and data analysis tool
enhancements</article-title>
<source/>Nucleic Acids Res.
          <year>2017</year>
<volume>45</volume>
<issue>D1</issue>
<fpage>D183</fpage>
<lpage>D189</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1138</pub-id>
<pub-id pub-id-type="pmid">27899595</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashburner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene ontology: tool for the unification of biology.
The Gene Ontology Consortium</article-title>
<source/>Nat Genet
          <year>2000</year>
<volume>25</volume>
<fpage>25</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/75556</pub-id>
<pub-id pub-id-type="pmid">10802651</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>The Gene Ontology Consortium.</collab>
</person-group>
<article-title>Expansion of the Gene Ontology knowledgebase and
resources</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<issue>D1</issue>
<fpage>D331</fpage>
<lpage>D338</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1108</pub-id>
<pub-id pub-id-type="pmid">27899567</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Perrimon</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Targeted gene expression as a means of altering cell
fates and generating dominant phenotypes</article-title>
<source/>Development
          <year>1993</year>
<volume>118</volume>
<fpage>401</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="pmid">8223268</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dietzl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schnorrer</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A genome-wide transgenic RNAi library for
conditional gene inactivation in Drosophila</article-title>
<source/>Nature
          <year>2007</year>
<volume>448</volume>
<fpage>151</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1038/nature05954</pub-id>
<pub-id pub-id-type="pmid">17625558</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bischof</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bjorklund</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schertel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Taipale</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Basler</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>A versatile platform for creating a comprehensive
UAS-ORFeome library in Drosophila</article-title>
<source/>Development
          <year>2013</year>
<volume>140</volume>
<fpage>2434</fpage>
<lpage>2442</lpage>
<pub-id pub-id-type="doi">10.1242/dev.088757</pub-id>
<pub-id pub-id-type="pmid">23637332</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straub</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>EDH</given-names>
</name>
<name>
<surname>Gruner</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Missense variants in RHOBTB2 cause a developmental
and epileptic encephalopathy in humans, and altered levels cause
neurological defects in Drosophila</article-title>
<source/>Am J Hum Genet
          <year>2018</year>
<volume>102</volume>
<fpage>44</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.11.008</pub-id>
<pub-id pub-id-type="pmid">29276004</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>van der Voet</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered GPM6A/M6 dosage impairs cognition and causes
phenotypes responsive to cholesterol in human and Drosophila</article-title>
<source/>Hum Mutat
          <year>2014</year>
<volume>35</volume>
<fpage>1495</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22697</pub-id>
<pub-id pub-id-type="pmid">25224183</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koh</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Gramates</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Budnik</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Drosophila larval neuromuscular junction: molecular
components and mechanisms underlying synaptic plasticity</article-title>
<source/>Microsc Res Tech
          <year>2000</year>
<volume>49</volume>
<fpage>14</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0029(20000401)49:1&lt;14::AID-JEMT3&gt;3.0.CO;2-G</pub-id>
<pub-id pub-id-type="pmid">10757875</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirayama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tarusawa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Galjart</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>CTCF is required for neural development and
stochastic expression of clustered Pcdh genes in neurons</article-title>
<source/>Cell Rep
          <year>2012</year>
<volume>2</volume>
<fpage>345</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2012.06.014</pub-id>
<pub-id pub-id-type="pmid">22854024</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuebler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tanouye</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Modifications of seizure susceptibility in
Drosophila</article-title>
<source/>J Neurophysiol
          <year>2000</year>
<volume>83</volume>
<fpage>998</fpage>
<lpage>1009</lpage>
<pub-id pub-id-type="doi">10.1152/jn.2000.83.2.998</pub-id>
<pub-id pub-id-type="pmid">10669511</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palladino</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hadley</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Ganetzky</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Temperature-sensitive paralytic mutants are enriched
for those causing neurodegeneration in Drosophila</article-title>
<source/>Genetics
          <year>2002</year>
<volume>161</volume>
<fpage>1197</fpage>
<lpage>1208</lpage>
<pub-id pub-id-type="pmid">12136022</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Conditioned responses in courtship behavior of
normal and mutant Drosophila</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1979</year>
<volume>76</volume>
<fpage>3430</fpage>
<lpage>3434</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.76.7.3430</pub-id>
<pub-id pub-id-type="pmid">16592682</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rabaia</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of maternal CTCF is associated with
peri-implantation lethality of Ctcf null embryos</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e34915</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0034915</pub-id>
<pub-id pub-id-type="pmid">22532833</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Elbert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kernohan</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Galjart</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Berube</surname>
<given-names>NG</given-names>
</name>
</person-group>
<article-title>Dual effect of CTCF loss on neuroprogenitor
differentiation and survival</article-title>
<source/>J Neurosci
          <year>2014</year>
<volume>34</volume>
<fpage>2860</fpage>
<lpage>2870</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3769-13.2014</pub-id>
<pub-id pub-id-type="pmid">24553927</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Filippova</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Loukinov</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CTCF is conserved from Drosophila to humans and
confers enhancer blocking of the Fab-8 insulator</article-title>
<source/>EMBO Rep
          <year>2005</year>
<volume>6</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1038/sj.embor.7400334</pub-id>
<pub-id pub-id-type="pmid">15678159</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambetta</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Furlong</surname>
<given-names>EEM</given-names>
</name>
</person-group>
<article-title>The insulator protein CTCF is required for correct
Hox gene expression, but not for embryonic development in
Drosophila</article-title>
<source/>Genetics
          <year>2018</year>
<volume>210</volume>
<fpage>129</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1534/genetics.118.301350</pub-id>
<pub-id pub-id-type="pmid">30021792</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Linder-Basso</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kharchenko</surname>
<given-names>PV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nature and function of insulator protein binding
sites in the Drosophila genome</article-title>
<source/>Genome Res
          <year>2012</year>
<volume>22</volume>
<fpage>2188</fpage>
<lpage>2198</lpage>
<pub-id pub-id-type="doi">10.1101/gr.138156.112</pub-id>
<pub-id pub-id-type="pmid">22767387</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>